AMARIN CORP PLC\UK (AMRN) Form 10-K Annual Reports
AMARIN CORP PLC\UK (AMRN) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AMRN
CIK: 897448
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: X0
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerStephen Muretta
Audit LocationIselin, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13D/A | 2026-08-27 | — | SCHEDULE 13D/A Filing | 0000899140-26-000972 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-08-01 | 4 | 0001193125-26-330669 | View SEC Doc Filr Page |
| 10-Q | 2026-07-29 | 2026-06-30 | 10-Q | 0001193125-26-323845 | View SEC Doc Filr Page |
| 8-K | 2026-07-29 | 2026-07-29 | 8-K | 0001193125-26-323841 | View SEC Doc Filr Page |
| 4 | 2026-07-15 | 2026-07-01 | 4 | 0001193125-26-304914 | View SEC Doc Filr Page |
| 4 | 2026-07-15 | 2026-07-01 | 4 | 0001193125-26-304912 | View SEC Doc Filr Page |
| 4 | 2026-07-15 | 2026-07-01 | 4 | 0001193125-26-304911 | View SEC Doc Filr Page |
| 4 | 2026-07-15 | 2026-07-01 | 4 | 0001193125-26-304910 | View SEC Doc Filr Page |
| 4 | 2026-06-30 | 2026-06-26 | 4 | 0001193125-26-290834 | View SEC Doc Filr Page |
| 8-K | 2026-05-15 | 2026-05-13 | 8-K | 0001193125-26-224771 | View SEC Doc Filr Page |
| 10-Q | 2026-04-29 | 2026-03-31 | 10-Q | 0001193125-26-188940 | View SEC Doc Filr Page |
| 8-K | 2026-04-29 | 2026-04-29 | 8-K | 0001193125-26-188935 | View SEC Doc Filr Page |
| 4 | 2026-04-22 | 2026-04-18 | 4 | 0001193125-26-170731 | View SEC Doc Filr Page |
| 4 | 2026-04-21 | 2026-04-18 | 4 | 0001193125-26-167117 | View SEC Doc Filr Page |
| 4 | 2026-04-21 | 2026-04-18 | 4 | 0001193125-26-167114 | View SEC Doc Filr Page |
| 4 | 2026-04-21 | 2026-04-18 | 4 | 0001193125-26-167119 | View SEC Doc Filr Page |
| 4 | 2026-04-21 | 2026-04-18 | 4 | 0001193125-26-167113 | View SEC Doc Filr Page |
| 4 | 2026-04-21 | 2026-04-18 | 4 | 0001193125-26-167118 | View SEC Doc Filr Page |
| 4 | 2026-04-21 | 2026-04-18 | 4 | 0001193125-26-167112 | View SEC Doc Filr Page |
| ARS | 2026-04-10 | 2025-12-31 | ARS | 0001193125-26-151420 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-10 | 2026-04-10 | DEF 14A | 0001193125-26-151417 | View SEC Doc Filr Page |
| 4 | 2026-04-02 | 2026-04-01 | 4 | 0001193125-26-140264 | View SEC Doc Filr Page |
| PRE 14A | 2026-03-30 | 2026-03-30 | PRE 14A | 0001193125-26-132114 | View SEC Doc Filr Page |
| 8-K | 2026-03-27 | 2026-03-25 | 8-K | 0001193125-26-129334 | View SEC Doc Filr Page |
| 10-K | 2026-03-02 | 2025-12-31 | 10-K | 0001193125-26-085818 | View SEC Doc Filr Page |